Analysis and Perspectives

Nov 08, 2024

It is estimated that the cervical cancer treatment space will experience significant changes during the forecast period of 2024–2034. The future is brighter for patients with cervical cancer. Targeted agents and biomarker-driven therapies hold promise for improved outcomes both as single agents and combinations.

Nov 08, 2024

The HPV vaccine protects against several types of HPV that can cause different types of cancers, which mainly include cervical cancer

Oct 18, 2024

The dynamics of the schizophrenia treatment market is expected to change in future. Key companies are evaluating lead assets to improve treatment space.

Oct 10, 2024

The GBM market size in the 7MM following the launch of a few of many emerging therapies is likely to reach 1,083 million by 2023.

Sep 30, 2024

Pompe Disease Therapeutics market is evolving immensely with the active participation of key companies such as Sanofi, Actus, Amicus

Aug 23, 2024

Several pharmaceutical companies are developing a gene therapy that will positively impact the Duchenne Muscular Dystrophy Treatment Market

Aug 20, 2024

As per DelveInsight, the DMD market is expected to generate over $8,000 million in revenue in the 7MM

Jul 25, 2024

BMS has established a comprehensive treatment strategy, with CELMODs replacing REVLIMID in earlier lines of multiple myeloma treatment.

May 29, 2024

Artificial blood vessels represent a critical frontier in medical research, offering significant promise for treating cardiovascular diseases and enhancing surgical outcomes. Future directions in this field are focused on developing materials that can closely mimic the natural properties of human blood vessels.

May 27, 2024

Potential therapies are being investigated for retinal vein occlusion treatment. Even though it is too soon to comment on the promising candidate to enter the market, it is safe to assume that the future of the retinal vein occlusion treatment market is promising.